INO

#4100
Inovio Pharmaceuticals, Inc.
1.19 USD
+7.21%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.19
1.19
Year Range
1.03
2.98
Daily Change
+7.21%
Monthly Change
-27.88%
6 month change
-51.23%
Year Change
-30.81%
Previous Close
1.11
Open
1.19
Bid
Ask
Low
1.19
High
1.19
Volume
25
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 82.22 M
  • Employee 112
  • Founded 1999
  • CEO Jacqueline Shea
  • Website www.inovio.com
  • Headquarter Delaware, United States
  • FIGI BBG000BK6YX5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.96
Price to sales ratio
1 248.52

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

News